Results 281 to 290 of about 95,754 (365)

Inflammation and Cancer: Molecular Mechanisms and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Chronic inflammation fuels tumorigenesis via “internal drivers” and “external attractions.” Targeting these core mechanisms with combined therapies/novel deliveries enables precise, potent anti‐inflammatory–antitumor treatment. ABSTRACT Inflammation is a core pathological factor regulating tumor initiation, progression, and therapeutic resistance, and ...
Xiaodie Liu, Ziyuan Wang, Huirong Zhu, Yicun Han, Qing Ji   +4 more
wiley   +1 more source

A review of adult and pediatric post-transplant liver pathology. [PDF]

, 1987
Demetris, AJ, Jaffe, R, Starzl, TE
core  

Mechanism of formation and significance of antimitochondrial autoantibodies in the pathogenesis of primary biliary cholangitis [PDF]

V. I. Reshetnyak, И. В. Маев
openalex   +1 more source

Impact of the prognostic nutritional index on the recompensation of patients with decompensated primary biliary cholangitis. [PDF]

Front Immunol
Yu C, Ni F, Zheng M, Duan Z, Yang W, Huang M, Xu H, Li M, Chen S, Gu C, Yang J, Liu J, Lei H, Yan S.   +13 more
europepmc   +1 more source

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu, Zhi‐Ping Jin, Shu‐Qiang Weng, Ji‐Min Zhu, Ling Dong   +4 more
wiley   +1 more source

A case of eosinophilic annular erythema as a presenting sign for primary biliary cholangitis

Pablo Sanz, Noelia de Sande Rivera, Claudia Guerrero Ramírez, Silvia Manso Córdoba, Carlota Rodríguez de Vera Guardiola, Eduardo Escario Travesedo   +5 more
openalex   +1 more source

Correction to 'Quality Measures to Enhance the Management and Treatment of Primary Biliary Cholangitis: A Delphi Consensus Study'. [PDF]

Liver Int
europepmc   +1 more source

Evolving therapeutic landscape of primary biliary cholangitis: A review. [PDF]

World J Hepatol
Mitchell NE, Chan SY, Jerez Diaz D, Ansari N, Lee J, Twohig P.   +5 more
europepmc   +1 more source

Was Motorized Spiral Enteroscopy Too Risky? A Systematic Review and Meta‐Analysis Including German Registry Data

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background and Study Aims Motorized spiral enteroscopy (MSE) was introduced as a major advancement in small‐bowel enteroscopy, enabling higher complete enteroscopy rates with shorter procedure times. However, after a fatal adverse event (AE) involving severe esophageal injury, the device was withdrawn from the market in July 2023.
Ingo Steinbrück, Armin Kuellmer, Siegbert Faiss, Hendrik Buchholz, Björn Lewerenz, Daniel Fitting, Felix Wiedbrauck, Stephan Hollerbach, Arthur Schmidt, Johannes Wilhelm Rey, Martha M. Kirstein, Franz‐Ludwig Dumoulin, Fabian Maximilian Wittich, Andreas Wannhoff, Jürgen Pohl, Matthias Friesicke, Viktor Rempel, Hans‐Peter Allgaier, Christian Wiessner, Thomas Rösch   +19 more
wiley   +1 more source

Causal association between dietary factors and Primary Biliary Cholangitis: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Luo H, Han L, He K, Chen K, Wei Q, Zhang C, Jiang L.   +6 more
europepmc   +1 more source